WallStSmart
NBP

NovaBridge Biosciences

NASDAQ: NBP · HEALTHCARE · BIOTECHNOLOGY

$2.35
-1.67% today

Updated 2026-04-29

Market cap
$271.77M
P/E ratio
P/S ratio
25.39x
EPS (TTM)
$-0.48
Dividend yield
52W range
$1 – $7
Volume
0.9M

NovaBridge Biosciences (NBP) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$11.56M$53.78M$30.00M$1.54B$88.03M$-10.70M$4.49M$0.00$0.00
Revenue growth (YoY)+365.4%-44.2%+5042.2%-94.3%-112.2%+141.9%-100.0%
Cost of revenue$46.43M$27.24M$0.00$6.00M
Gross profit$11.56M$53.78M$30.00M$1.54B$41.59M$-248.80M$4.49M$-6.00M
Gross margin100.0%100.0%100.0%100.0%47.3%2325.8%100.0%
R&D$267.07M$426.03M$840.41M$984.69M$190.29M$155.51M$114.36M$158.90M$62.91M
SG&A$25.44M$66.39M$654.55M$402.41M$899.94M$815.77M$63.91M$216.46M$31.36M
Operating income$-280.95M$-438.64M$-1.46B$155.57M$-2.07B$-366.08M$-511.16M$-375.36M$-660.93M
Operating margin-2431.2%-815.6%-4883.2%10.1%-2353.1%3422.2%-11395.1%
EBITDA$-279.32M$-431.90M$-197.26M$168.31M$-2.06B$-51.23M$-344.25M$-373.45M$-93.41M
EBITDA margin-2417.1%-803.1%-657.5%10.9%-2337.4%478.9%-7674.2%
EBIT$-280.95M$-438.64M$-207.09M$155.57M$-2.07B$-52.65M$-347.62M$-375.36M$-94.27M
Interest expense$864338.00$1.70M$427481.00$146480.00$0.00$1304.00$101854.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-298.24M$-402.83M$-1.49B$470.92M$-2.33B$-2.51B$-1.47B$-162.26M$-46.27M
Net income growth (YoY)-35.1%-268.6%+131.7%-595.1%-7.5%+41.5%+88.9%+71.5%
Profit margin-2580.8%-749.0%-4950.0%30.5%-2648.7%23438.9%-32674.0%